Granules India, Jubilant Cadista recall products in US ruchika13 Sep 2021 7:53 AM GMTNew Delhi: Generic drug makers Granules India and Jubilant Cadista are recalling different products in the US, the world's largest market for medicines...
Suven Life Sciences announces initiation of phase 3 trial of Alzheimer's drug Medical Dialogues Team22 Aug 2021 4:45 AM GMTHyderabad: Biopharmaceutical company, Suven Life Sciences, has announced the initiation of a phase 3 clinical trial of SUVN-502 (Masupirdine), a 5-HT6 ...
Widespread pain tied to increased risk of dementia and stroke: Study Hina Zahid17 Aug 2021 3:30 AM GMTThe findings provide convincing evidence that [widespread pain] may be a risk factor for all-cause dementia, [Alzheimer's disease], and stroke.USA: Peo...
AAN issues updated ethical guidelines for dementia diagnosis and care Hina Zahid20 July 2021 6:00 AM GMTUSA: The American Academy of Neurology (AAN) has issued an ethical guideline for dementia diagnosis and care. The guideline, published in the AAN...
GSK, Alector enter USD 2.2 billion deal for Parkinson's, Alzheimer's drugs ruchika5 July 2021 5:30 AM GMTUK: GlaxoSmithKline Plc and U.S. firm Alector Inc will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar d...
Biogen, Eisai secure USFDA accelerated nod for Alzheimer drug ADUHELM ruchika8 Jun 2021 10:27 AM GMTCambridge: Biogen and Eisai, Co., Ltd. have announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated approv...
Novel drug targeting amyloid plaques offers tentative hope for Alzheimer's patients, NEJM study Dr. Shivi Kataria8 May 2021 4:00 AM GMTA hallmark of Alzheimer's disease is the accumulation of amyloid-β (Aβ) peptide. Donanemab, an antibody that targets a modified form of deposited Aβ wa...
New Blood test for depression, bipolar disorder developed Hina Zahid12 April 2021 1:30 PM GMTWhile current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine...
Treating sleep apnea may reduce dementia risk Hina Zahid12 April 2021 3:00 AM GMTA new study finds older adults who received positive airway pressure therapy prescribed for obstructive sleep apnea may be less likely to develop...
Midlife loneliness is a risk factor for Dementia and Alzheimer's disease Hina Zahid25 March 2021 4:15 PM GMTBoston) - Being persistently lonely during midlife (ages 45-64) appears to make people more likely to develop dementia and Alzheimer's Disease (AD)...
Treatable sleep disorder common in people with thinking and memory problems: Study Hina Zahid4 March 2021 1:45 PM GMTMINNEAPOLIS - Obstructive sleep apnea is when breathing is repeatedly interrupted during sleep. Research has shown people with this sleep disorder...
Supplemental oxygen to mothers during childbirth of no benefit to infants: JAMA Hina Zahid4 Jan 2021 4:15 PM GMTBabies who suffer oxygen deficiencies during birth are at risk of brain damage that can lead to developmental delays, cerebral palsy and even death....
